Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 22 pseudogene 2 (RBM22P2) is annotated as a human pseudogene related to the protein-coding gene RNA binding motif protein 22 (RBM22)[6]. Pseudogenes such as RBM22P2 are defective genomic copies of protein-coding genes that have lost their protein-coding ability due to mutations or deletions, and they are not known to encode functional proteins or to serve as therapeutic targets. There are a number of related RBM22 pseudogenes in the human genome, scattered across chromosomes, but none are classified as functional drug targets or have mechanistic or disease associations[3][4][6]. Key clarification: - The protein-coding gene RNA binding motif protein 22 (RBM22) encodes a multifunctional RNA-binding protein involved in essential processes such as pre-mRNA splicing and gene regulation with implications in cell survival and cancer; however, RBM22P2 specifically is a non-coding pseudogene and does not share these functions[2][3][4][6]. - There are no clinical drugs, biomarkers, or disease indications related to RBM22P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 22 pseudogene 2 (RBM22P2).